Latest Inovio News

Powering a New Decade of DNA Medicines

INOVIO’s first-of-their-kind DNA medicines are precisely designed DNA plasmids delivered through INOVIO’s proprietary smart device — CELLECTRA® — directly into the body’s cells to produce an immune response robust enough to potentially treat or prevent disease.

How INOVIO’s DNA Medicines Work: MOA

video

COMMITTED TO SAVING AND PROTECTING LIVES WORLDWIDE

OUR FOCUS:
SERVING PATIENTS WITH URGENT HEALTH NEEDS

Watch the videos below to learn more about how INOVIO is powering a new decade of DNA medicines, inspired by patients with urgent health needs

J. JOSEPH KIM, Ph.D.

President & Chief Executive Officer

LAURENT HUMEAU, Ph.D.

Chief Scientific Officer

KATE E. BRODERICK, Ph.D.

Senior Vice President, R&D

ROBB

Patient with Recurrent Respiratory Papillomatosis (RRP)